Top Markets
Coin of the day
TCR2 Therapeutics Inc. TCR2 Therapeutics Inc.

TCR2 Therapeutics Inc.

TCRR
Rang în acțiuni #27038
TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on... TCR2 Therapeutics Inc. is a clinical-stage immunotherapy firm focused on developing cutting-edge T cell receptor (TCR) therapies for cancer patients. The company's lead investigational treatment, gavo-cel, is a unique mono TCR Fusion Construct T cell (TRuC-T cell) designed to target mesothelin-positive solid tumors. This therapy is currently being evaluated in Phase I/II clinical trials for non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. Furthermore, TCR2 Therapeutics has concluded preclinical development for TC-510, another TRuC-T cell specifically engineered to target mesothelin on solid tumors. They are also advancing TC-520, a CD70-targeting TRuC-T cell designed with fratricide resistance for treating renal cell carcinoma. Founded in 2015, the company, formerly known as TCR2, Inc. until its name change in November 2016, is headquartered in Cambridge, Massachusetts.
Preț acțiune
$1.48
Ultima sincronizare: 2023-05-31
Capitalizare de piață
$35.54M
Schimbare (1 zi)
-5.73%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează TCR2 Therapeutics Inc. (TCRR)

Categorie

Istoricul spliturilor pentru TCR2 Therapeutics Inc. (TCRR)
Acțiunea TCR2 Therapeutics Inc. (simbol: TCRR) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 20, 2026.
O acțiune TCRR cumpărată înainte de Aug 20, 2026 este echivalentă astăzi cu 0 acțiuni TCRR.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH